Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi… - … journal of chronic …, 2018 - Taylor & Francis
Recently, two “fixed triple” single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting β2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have …
被引用次数：73 相关文章

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi… - … journal of chronic …, 2018 - cris.maastrichtuniversity.nl
Recently, two" fixed triple" single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting beta (2)-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have …

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi… - … journal of chronic …, 2018 - pubmed.ncbi.nlm.nih.gov
Recently, two" fixed triple" single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting β 2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have …

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi… - … JOURNAL OF COPD, 2018 - sfera.unife.it
Recently, two" fixed triple" single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting beta (2)-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have …

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi… - International Journal of …, 2018 - go.gale.com
Recently, two" fixed triple" single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting [[beta]. sub. 2]-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) …
[HTML] nih.gov

[HTML][HTML] Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi… - … Journal of Chronic …, 2018 - ncbi.nlm.nih.gov
Recently, two “fixed triple” single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting β 2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have …

[引用][C] Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal

L Vanfleteren, LM Fabbri, A Papi, S Petruzzelli… - International Journal of …, 2018 - cir.nii.ac.jp
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.

L Vanfleteren, LM Fabbri, A Papi… - International Journal of …, 2018 - europepmc.org
Recently, two “fixed triple” single-inhaler combinations of an inhaled corticosteroid (ICS), a
long-acting β 2-agonist (LABA), and a long-acting muscarinic antagonist (LAMA) have …